Complete deficiency of adenine phosphoribosyltransferase. Report of a family.
We studied the clinical and biochemical manifestations of complete adenine phosphoribosyltransferase deficiency in the kindred of a male homozygous child excreting stones of 2,8-dihydroxyade-nine. Abnormal amounts of adenine, 8-hydroxyade-nine and 2,8-dihydroxyadenine (25 per cent of total purine metabolites) appeared in the urine of the propositus and his clinically normal brother, but not in heterozygotes or a control. Adenine phosphoribosyl-transferase activity in erythrocytes was less than 1 per cent of normal in both homozygotes and varied from 20 to 57 per cent of normal in six heterozygotes. Heterozygotes exhibited neither hyperuricemia nor gout. Treatment of the propositus with allopurinol and a low purine diet stopped stone formation. In addition, excretion of 2,8-dihydroxyadenine decreased. An autosomal recessive mode of inheritance with variable expression in the phenotype is indicated. Homozygotes may be detected by their raised urinary adenine levels or absence of detectable erythrocyte adenine phosphoribosyltransferase activity (or both).
D000225:Adenine / Q000378:metabolism; D000228:Adenine Phosphoribosyltransferase / Q000172:deficiency*; D000493:Allopurinol / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003460:Crystallization; D005260:Female; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007223:Infant; D008297:Male; D010375:Pedigree; D010430:Pentosyltransferases / Q000172:deficiency*; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000235:genetics* / Q000378:metabolism / Q000628:therapy; D011687:Purines / Q000652:urine; D014527:Uric Acid / Q000097:blood; D014545:Urinary Calculi / Q000209:etiology / Q000378:metabolism
D011687:Purines; D014527:Uric Acid; D000493:Allopurinol; D010430:Pentosyltransferases; D000228:Adenine Phosphoribosyltransferase; D000225:Adenine